These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 6795047

  • 1. Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.
    Christiansen C, Christensen MS, Rødbro P, Hagen C, Transbøl I.
    Eur J Clin Invest; 1981 Aug; 11(4):305-9. PubMed ID: 6795047
    [Abstract] [Full Text] [Related]

  • 2. Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.
    Jensen GF, Christiansen C, Transbøl I.
    Clin Endocrinol (Oxf); 1982 May; 16(5):515-24. PubMed ID: 7044620
    [Abstract] [Full Text] [Related]

  • 3. Does 1,25(OH)2D3 accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women.
    Jensen GF, Meinecke B, Boesen J, Transbøl I.
    Clin Orthop Relat Res; 1985 May; (192):215-21. PubMed ID: 3881203
    [Abstract] [Full Text] [Related]

  • 4. Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosis.
    Caniggia A, Delling G, Nuti R, Lorè F, Vattimo A.
    Acta Vitaminol Enzymol; 1984 May; 6(2):117-28. PubMed ID: 6388277
    [Abstract] [Full Text] [Related]

  • 5. Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women.
    Riis BJ, Johansen J, Christiansen C.
    Maturitas; 1988 May; 10(1):51-8. PubMed ID: 3041248
    [Abstract] [Full Text] [Related]

  • 6. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females.
    Christiansen C, Christensen MS, McNair P, Hagen C, Stocklund KE, Transbøl I.
    Eur J Clin Invest; 1980 Aug; 10(4):273-9. PubMed ID: 6253303
    [Abstract] [Full Text] [Related]

  • 7. Does postmenopausal bone loss respond to estrogen replacement therapy independent of bone loss rate?
    Christiansen C, Rødbro P.
    Calcif Tissue Int; 1983 Sep; 35(6):720-2. PubMed ID: 6652546
    [Abstract] [Full Text] [Related]

  • 8. Does 24R,25(OH)2-vitamin D3 prevent postmenopausal bone loss?
    Riis BJ, Thomsen K, Christiansen C.
    Calcif Tissue Int; 1986 Sep; 39(3):128-32. PubMed ID: 3093022
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Postmenopausal osteoporosis: no effect of three years treatment with 1,25-dihydroxycholecalciferol.
    Falch JA, Odegaard OR, Finnanger AM, Matheson I.
    Acta Med Scand; 1987 Sep; 221(2):199-204. PubMed ID: 3035879
    [Abstract] [Full Text] [Related]

  • 14. Serum bone Gla protein variations during estrogen and calcium prophylaxis of postmenopausal women.
    Pødenphant J, Christiansen C, Catherwood BD, Deftos LJ.
    Calcif Tissue Int; 1984 Sep; 36(5):536-40. PubMed ID: 6441624
    [Abstract] [Full Text] [Related]

  • 15. Prevention of bone mineral loss in postmenopausal women by norethisterone.
    Abdalla HI, Hart DM, Lindsay R, Leggate I, Hooke A.
    Obstet Gynecol; 1985 Dec; 66(6):789-92. PubMed ID: 4069480
    [Abstract] [Full Text] [Related]

  • 16. Changes in bone mineral content in women with natural menopause during treatment with female sex hormones.
    Dalén N, Furuhjelm M, Jacobson B, Lamke B.
    Acta Obstet Gynecol Scand; 1978 Dec; 57(5):435-7. PubMed ID: 726877
    [Abstract] [Full Text] [Related]

  • 17. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM, Gordeladze JO, Lyngdal PT, Aarseth HP, Gautvik KM.
    Miner Electrolyte Metab; 1993 Dec; 19(2):78-85. PubMed ID: 8377728
    [Abstract] [Full Text] [Related]

  • 18. Treatment with vitamin 24,25 (OH)2D3 does not change serum levels of 1,25 (OH)2D or urinary calcium excretion rate in man.
    Thomsen K, Riis BJ, Hummer L, Christiansen C.
    Acta Vitaminol Enzymol; 1985 Dec; 7(3-4):167-71. PubMed ID: 3879105
    [Abstract] [Full Text] [Related]

  • 19. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM, Gautvik KM, Gordeladze JO.
    Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
    [Abstract] [Full Text] [Related]

  • 20. Effect of vitamin D metabolites on bone metabolism in a rat model of postmenopausal osteoporosis.
    Matsumoto T, Ezawa I, Morita K, Kawanobe Y, Ogata E.
    J Nutr Sci Vitaminol (Tokyo); 1985 Dec; 31 Suppl():S61-5. PubMed ID: 3915757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.